Topical Pain Relief Market
Global Topical Pain Relief Market Size, Share & Trends Analysis Report by Type (Prescribed and Over the Counter (OTC)), by Drug Class (Non-Opioids and Opioids), and by Formulation Type (Creams, Gels, Roll-Ons, Sprays, Sticks, Patches, and Others (Foams, Oils)) Forecast, 2020-2026 Update Available - Forecast 2024-2030
Pain relievers are also called Analgesics. These are a class of medications designed specifically to relieve pain. Analgesics are often being used to get relief in abdominal pain, arthritis, back pain, carpal tunnel syndrome, fibromyalgia, hip pain, knee pain, foot pain, lupus, migraine, nerve pain, osteoarthritis, and rheumatoid arthritis. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) is a major class of analgesics available OTC across the globe. The global Topical Pain Relief market is projected to grow at a CAGR of 4.7% during the forecast period (2020-2026). The major aspect that drives the growth of the market includes the rising cases of chronic pain conditions along with the people across the globe.
According to the Center for Disease Control & Prevention, in 2018, around 20.4% (50 million) of US adults had chronic pain and 8.0% of US adults (19.6 million) had high-impact chronic pain. The high prevalence of chronic pain in the US population creates demand for easily available topical pain relievers to get instant relief in case of chronic pain. Hence, with an emerging chronic pain condition, the topical route for pain management has seen witnessed great interest, owing to its potential to deliver therapeutic doses of medication directly to a targeted area. Besides, some medications may lead to particular side effects whereas, the topical ointments target a specific part; and in cases of light to moderate psoriasis stages, the topical ointments are mostly preferred.
However, some of the factors that must be kept in mind are dosage form, cost, ease of use, odor, and the patient’s medical history, including possible allergies. These factors may create challenges to the growth of the topical pain relief market during the forecast period.
Segmental Outlook
The global Topical Pain Relief market is segmented on the basis of type, drug class, and formulation type. Based on the type, the market is segmented as prescribed and over the counter (OTC). Based on the drug class, the market is segmented as non-opioids and opioids. Based on the formulation type, the market is segmented as creams, gels, roll-ons, sprays, sticks, patches, and others. The other segment includes foams and oils.
Non-Opioids Segment to Hold a Significant Market Share
Amongst the drug class segment of the global topical pain relief, the non-opioids segment is projected to hold the most lucrative share in the market. The segmental growth of the market is accredited to the increased preferences of these drugs as these non-opioids are over-the-counter drugs. Non-opioid analgesics include a variety of drugs such as non-steroidal anti-inflammatory drugs (NSAIDs), paracetamol (acetaminophen), acetylsalicylic acid (ASA, aspirin), dipyrone (metamizole), and numerous other drugs in diverse classes; which again is a major aspect driving the segmental growth of the market during the forecast period. Besides, topical non-opioids are also found to be more effective in the treatment of acute pain from sprains, strains, contusions, or overuse injuries in superficial locations. Further, National Institute for Health and Care Excellence (NICE) has also approved topical NSAIDs for joint pain associated with osteoarthritis over the prescription of oral NSAIDs. Hence, attributing to such a wide range of features and preferences, the segment is likely to witness substantial growth.
Global Topical Pain Relief Market, by Drug Class 2019 (%)
Regional Outlook
The global topical pain relief market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region is projected to hold a significant market share. The US and Canada are the major economies primarily contributing to the growth of the topical pain relief market in the region. The regional growth of the market is accredited to the presence of well-established healthcare facilities in the region along with the rising prevalence of chronic pain owing to the growing geriatric population in the region. Besides, the presence of the key players operating in the region also contributes to the growth of the market. Players such as GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. are substantially supporting the regional growth during the forecast period.
Global Topical Pain Relief Market, by Region 2019 (%)
Market Players Outlook
The prominent players functioning in the global Topical Pain Relief market include GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and The Himalayan Drug Co. among others. These key manufacturers are adopting various strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, and many others in order to thrive in a competitive environment.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Topical Pain Relief market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Topical Pain Relief Market by Type
5.1.1. Prescribed
5.1.2. Over the Counter (OTC)
5.2. Global Topical Pain Relief Market by Drug Class
5.2.1. Non-Opioids
5.2.2. Opioids
5.3. Global Topical Pain Relief Market by Formulation Type
5.3.1. Creams
5.3.2. Gels
5.3.3. Roll-Ons
5.3.4. Sprays
5.3.5. Sticks
5.3.6. Patches
5.3.7. Others (Foams, Oils)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. ASEAN
6.3.5. South Korea
6.3.6. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AdvaCare Pharma
7.2. Chattem, Inc.
7.3. Emami Group
7.4. Exzell Pharma Inc.
7.5. GlaxoSmithKline Plc
7.6. Hisamitsu Pharmaceutical Co., Inc.
7.7. Johnson & Johnson Services Inc.
7.8. Novartis AG
7.9. Pfizer Inc.
7.10. Reckitt Benckiser Group Plc
7.11. Sanofi SA
7.12. Sun Pharmaceutical Industries Ltd.
7.13. Teva Pharmaceutical Industries Ltd.
7.14. The Himalayan Drug Co.
7.15. Topical BioMedics, Inc.
7.16. Troy Healthcare LLC
1. GLOBAL TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
2. GLOBAL PRESCRIBED TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL OVER THE COUNTER (OTC) TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
5. GLOBAL NON-OPIOIDS TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL OPIOIDS TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2019-2026 ($ MILLION)
8. GLOBAL TOPICAL PAIN RELIEF CREAMS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL TOPICAL PAIN RELIEF GELS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
10. GLOBAL TOPICAL PAIN RELIEF ROLL-ONS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL TOPICAL PAIN RELIEF SPRAYS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. GLOBAL TOPICAL PAIN RELIEF STICKS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
13. GLOBAL TOPICAL PAIN RELIEF PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
14. GLOBAL TOPICAL PAIN RELIEF OTHER FORMULATION TYPES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
15. GLOBAL TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
16. NORTH AMERICAN TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
17. NORTH AMERICAN TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
18. NORTH AMERICAN TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
19. NORTH AMERICAN TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2019-2026 ($ MILLION)
20. EUROPEAN TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
21. EUROPEAN TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
22. EUROPEAN TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
23. EUROPEAN TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2019-2026 ($ MILLION)
24. ASIA-PACIFIC TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
25. ASIA-PACIFIC TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
26. ASIA-PACIFIC TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
27. ASIA-PACIFIC TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2019-2026 ($ MILLION)
28. REST OF THE WORLD TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
29. REST OF THE WORLD TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2019-2026 ($ MILLION)
30. REST OF THE WORLD TOPICAL PAIN RELIEF MARKET RESEARCH AND ANALYSIS BY FORMULATION TYPE, 2019-2026 ($ MILLION)
1. GLOBAL TOPICAL PAIN RELIEF MARKET SHARE BY TYPE, 2019 VS 2026 (%)
2. GLOBAL TOPICAL PAIN RELIEF MARKET SHARE BY DRUG CLASS, 2019 VS 2026 (%)
3. GLOBAL TOPICAL PAIN RELIEF MARKET SHARE BY FORMULATION TYPE, 2019 VS 2026 (%)
4. GLOBAL TOPICAL PAIN RELIEF MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
5. US TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
6. CANADA TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
7. UK TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
8. FRANCE TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
9. GERMANY TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
10. ITALY TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
11. SPAIN TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
12. ROE TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
13. INDIA TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
14. CHINA TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
15. JAPAN TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
16. ASEAN TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
17. SOUTH KOREA TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
18. REST OF ASIA-PACIFIC TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
19. REST OF THE WORLD TOPICAL PAIN RELIEF MARKET SIZE, 2019-2026 ($ MILLION)
